Ramírez-Gómez, Carolina C

Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease. [electronic resource] - Clinical neuropharmacology - 14-16 p. digital

Publication Type: Case Reports; Journal Article

1537-162X

10.1097/WNF.0000000000000316 doi


Aged
Antiparkinson Agents--administration & dosage
Blepharospasm--chemically induced
Botulinum Toxins, Type A--adverse effects
Carbidopa--adverse effects
Drug Combinations
Dyskinesias--drug therapy
Humans
Levodopa--administration & dosage
Male
Middle Aged
Parkinson Disease--drug therapy